Pharmafile Logo

AI in the clinic: How AI is reshaping clinical behavior

November 18, 2026 |  

AI is becoming an increasingly important part of clinical practice, moving beyond administrative tasks to influence how physicians access information and make treatment decisions.

- PMLiVE

AI is moving beyond administrative tasks, influencing how physicians access clinical information and make treatment decisions. But how widely is it being used, and how much do physicians trust the information it provides?

In a survey of 836 US physicians by Inizio Ignite:

  • 82% report regularly using at least one AI platform.
  • 36% say AI has influenced their treatment-pathway selection.
  • Only 19% report high confidence in AI accuracy.

Our latest report, AI in the Clinic: How AI is Reshaping Clinical Behavior, also explores:

  • Which AI tools physicians use to access clinical information.
  • How they perceive the accuracy and reliability of AI.
  • What these changing behaviors could mean for pharma’s medical and commercial teams.

Read the full report here. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

AI in the clinic: How AI is reshaping clinical behavior

AI is becoming an increasingly important part of clinical practice, moving beyond administrative tasks to influence how physicians access information and make treatment decisions.

Oncology innovation: The human cost of keeping pace with advances in cancer care

New research from Inizio Evoke explores the growing complexity of oncology innovation and how pharmaceutical companies can better support healthcare professionals (HCPs).

AI-enabled biotech commercialization for a successful US therapy launch with Tonix

Inizio helped Tonix successfully launch the first FDA-approved therapy in its class in almost two decades by delivering an integrated, AI-enabled commercialization program spanning analytics, field operations, and launch readiness.

How pharma companies can use AI to scale personalized engagement without increasing complexity

AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI takes more than just introducing…

Creating the conditions for product launch success in a time of volatility

Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can change, and teams are increasingly expected to make confident decisions in response.

Navigating uncertainty in life sciences

The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and evolving patient needs are creating new challenges for organizations developing and commercializing treatments….

Inizio appoints Oisín Ó Gógáin as Chief People Officer

Inizio has appointed Oisín Ó Gógáin as Chief People Officer.

Pharma leadership strategies for talent, AI adoption, and continuous learning

In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous…

Smarter science, sharper strategy: Expert insights from ASCO® 2026

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.